Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma

Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a v...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao Wang, Jiexuan Lv, Changquan Huang, Xiaohong Li, Yongxiong Chen, Wutian Wu, Renyi Wu
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/423575dd41ed454da55d0417d8051795
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:423575dd41ed454da55d0417d8051795
record_format dspace
spelling oai:doaj.org-article:423575dd41ed454da55d0417d80517952021-11-08T02:35:37ZHuman Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma1687-967810.1155/2021/8852517https://doaj.org/article/423575dd41ed454da55d0417d80517952021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/8852517https://doaj.org/toc/1687-9678Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a viable therapeutic option, and human umbilical cord- (hUC-) MSCs are attractive candidates for cell-based neuroprotection. Here, we investigated the ability of transplanted hUC-MSCs to survive and migrate within the vitreous cavity and their neuroprotective effects on chronic glaucomatous retina. For this, we developed a chronic ocular hypertension (COH) rat model through the intracameral injection of allogeneic Tenon’s fibroblasts. Green fluorescent protein-transduced hUC-MSCs were then injected into the vitreous cavity one week after COH induction. Results showed that a moderate IOP elevation lasted for two months. Transplanted hUC-MSCs migrated toward the area of damaged retina, but did not penetrate into the retina. The hUC-MSCs survived for at least eight weeks in the vitreous cavity. Moreover, the hUC-MSCs were efficient at decreasing the loss of retinal ganglion cells; retinal damage was attenuated through the inhibition of apoptosis. In this study, we have developed a novel COH rat model and demonstrated the prolonged neuroprotective potential of intravitreal hUC-MSCs in chronic glaucoma.Yao WangJiexuan LvChangquan HuangXiaohong LiYongxiong ChenWutian WuRenyi WuHindawi LimitedarticleInternal medicineRC31-1245ENStem Cells International, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Internal medicine
RC31-1245
spellingShingle Internal medicine
RC31-1245
Yao Wang
Jiexuan Lv
Changquan Huang
Xiaohong Li
Yongxiong Chen
Wutian Wu
Renyi Wu
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
description Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a viable therapeutic option, and human umbilical cord- (hUC-) MSCs are attractive candidates for cell-based neuroprotection. Here, we investigated the ability of transplanted hUC-MSCs to survive and migrate within the vitreous cavity and their neuroprotective effects on chronic glaucomatous retina. For this, we developed a chronic ocular hypertension (COH) rat model through the intracameral injection of allogeneic Tenon’s fibroblasts. Green fluorescent protein-transduced hUC-MSCs were then injected into the vitreous cavity one week after COH induction. Results showed that a moderate IOP elevation lasted for two months. Transplanted hUC-MSCs migrated toward the area of damaged retina, but did not penetrate into the retina. The hUC-MSCs survived for at least eight weeks in the vitreous cavity. Moreover, the hUC-MSCs were efficient at decreasing the loss of retinal ganglion cells; retinal damage was attenuated through the inhibition of apoptosis. In this study, we have developed a novel COH rat model and demonstrated the prolonged neuroprotective potential of intravitreal hUC-MSCs in chronic glaucoma.
format article
author Yao Wang
Jiexuan Lv
Changquan Huang
Xiaohong Li
Yongxiong Chen
Wutian Wu
Renyi Wu
author_facet Yao Wang
Jiexuan Lv
Changquan Huang
Xiaohong Li
Yongxiong Chen
Wutian Wu
Renyi Wu
author_sort Yao Wang
title Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
title_short Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
title_full Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
title_fullStr Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
title_full_unstemmed Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
title_sort human umbilical cord-mesenchymal stem cells survive and migrate within the vitreous cavity and ameliorate retinal damage in a novel rat model of chronic glaucoma
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/423575dd41ed454da55d0417d8051795
work_keys_str_mv AT yaowang humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT jiexuanlv humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT changquanhuang humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT xiaohongli humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT yongxiongchen humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT wutianwu humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
AT renyiwu humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma
_version_ 1718443177445163008